Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review

详细信息    查看全文

• 作者：Shalvaree Vaidya ; Clare L. Hibbert ; Elizabeth Kinter ; Stefan Boes
• 关键词：Idiopathic pulmonary fibrosis ; Cost ; Economic impact ; Systematic review ; Cost triggers ; Financial burden
• 刊名：Lung
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：195
• 期：1
• 页码：1-8
• 全文大小：
• 刊物类别：Medicine
• 刊物主题：Pneumology/Respiratory System;
• 出版者：Springer US
• ISSN：1432-1750
• 卷排序：195

文摘

BackgroundIdiopathic pulmonary fibrosis (IPF) is an incurable, debilitating disease which impairs lung function and eventually leads to death. Currently, there is a lack of effective modifying therapies and treatments for IPF as the underlying epidemiological mechanism is not clearly understood. This leads to difficulty in diagnosing and managing IPF, which results in a high incurment of disease-associated cost. Even though IPF poses a substantial economic burden, there is a lack of research available on cost triggers and healthcare utilization, which can be a barrier to future economic evaluations of new medicines for IPF.